Tsuruda T et al. |
Angiotensin II Stimulation of Cardiac Hypertrophy and Functional Decompensation in Osteoprotegerin-Deficient Mice. |
2016 |
Hypertension |
pmid:27001297
|
Kats A et al. |
Aminothiazoles inhibit RANKL- and LPS-mediated osteoclastogenesis and PGE2 production in RAW 264.7 cells. |
2016 |
J. Cell. Mol. Med. |
pmid:26987561
|
Moran CS et al. |
Modulation of Kinin B2 Receptor Signaling Controls Aortic Dilatation and Rupture in the Angiotensin II-Infused Apolipoprotein E-Deficient Mouse. |
2016 |
Arterioscler. Thromb. Vasc. Biol. |
pmid:26966276
|
Cong Q et al. |
p38α MAPK Regulates Lineage Commitment and OPG Synthesis of Bone Marrow Stromal Cells to Prevent Bone Loss under Physiological and Pathological Conditions. |
2016 |
Stem Cell Reports |
pmid:26947973
|
Alam I et al. |
Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice. |
2016 |
Endocrinology |
pmid:26584014
|
Liu YD et al. |
Systemic administration of strontium or NBD peptide ameliorates early stage cartilage degradation of mouse mandibular condyles. |
2016 |
Osteoarthr. Cartil. |
pmid:26256766
|
Bergamini A et al. |
Expression of the receptor activator of nuclear factor-kB ligand in peripheral blood mononuclear cells in patients with acute Charcot neuroarthropathy. |
2016 |
Int J Med Sci |
pmid:28090190
|
Røysland R et al. |
Diagnostic and Prognostic Properties of Osteoprotegerin in Patients with Acute Dyspnoea: Observations from the Akershus Cardiac Examination (ACE) 2 Study. |
2016 |
PLoS ONE |
pmid:27463973
|
Piemontese M et al. |
Cortical bone loss caused by glucocorticoid excess requires RANKL production by osteocytes and is associated with reduced OPG expression in mice. |
2016 |
Am. J. Physiol. Endocrinol. Metab. |
pmid:27460899
|
Zhao JJ et al. |
MicroRNA-145 Mediates Steroid-Induced Necrosis of the Femoral Head by Targeting the OPG/RANK/RANKL Signaling Pathway. |
2016 |
PLoS ONE |
pmid:27459539
|